• Explore /
  • Poster
  • / Biomarker analysis and updated clinical follow-up from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with muscle-invasive bladder cancer (MIBC) undergoing cystectomy.

Biomarker analysis and updated clinical follow-up from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with muscle-invasive bladder cancer (MIBC) undergoing cystectomy.

Abstract Poster

Authors

Shilpa Gupta

Shilpa Gupta

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Shilpa Gupta , Ewan Gibb , Guru P. Sonpavde , Sumati Gupta , Benjamin L. Maughan , Neeraj Agarwal , Bradley Alexander McGregor , Christopher Weight , Xiao X. Wei , David Johnson Einstein , Christopher B. Dechet , Mark A. Preston , Matthew Mossanen , Bharat Thygarajan , Markus Eckstein , C. Marcela Diaz-Montero , Paari J. Murugan , Peter C. Black , Badrinath R. Konety

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT03294304

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 528)

DOI

10.1200/JCO.2022.40.6_suppl.528

Abstract #

528

Poster Bd #

H4

Abstract Disclosures

Similar Posters

First Author: Kamal Hammouda

First Author: Shilpa Gupta

First Author: Michael Lattanzi

First Author: Christopher J. Hoimes